Literature DB >> 31090940

Dysregulated Autophagy and Lysosome Function Are Linked to Exosome Production by Micro-RNA 155 in Alcoholic Liver Disease.

Mrigya Babuta1, Istvan Furi1, Shashi Bala1, Terence N Bukong1, Patrick Lowe1, Donna Catalano1, Charles Calenda1, Karen Kodys1, Gyongyi Szabo1.   

Abstract

Cellular homeostais, that is normally maintained through autophagy, is disrupted in alcoholic liver disease (ALD). Because autophagy and exosome biogenesis share common elements, we hypothesized that increased exosome production in ALD may be linked to disruption of autophagic function. We found impaired autophagy both in ALD and alcoholic hepatitis (AH) mouse models and human livers with ALD as indicated by increased hepatic p62 and LC3-II levels. Alcohol reduced autophagy flux in vivo in chloroquine-treated mice as well as in vitro in hepatocytes and macrophages treated with bafilomycin A. Our results revealed that alcohol targets multiple steps in the autophagy pathway. Alcohol-related decrease in mechanistic target of rapamycin (mTOR) and Ras homolog enriched in brain (Rheb), that initiate autophagy, correlated with increased Beclin1 and autophagy-related protein 7 (Atg7), proteins involved in phagophore-autophagosome formation, in ALD. We found that alcohol disrupted autophagy function at the lysosomal level through decreased lysosomal-associated membrane protein 1 (LAMP1) and lysosomal-associated membrane protein 2 (LAMP2) in livers with ALD. We identified that micro-RNA 155 (miR-155), that is increased by alcohol, targets mTOR, Rheb, LAMP1, and LAMP2 in the authophagy pathway. Consistent with this, miR-155-deficient mice were protected from alcohol-induced disruption of autophagy and showed attenuated exosome production. Mechanistically, down-regulation of LAMP1 or LAMP2 increased exosome release in hepatocytes and macrophages in the presence and absence of alcohol. These results suggested that the alcohol-induced increase in exosome production was linked to disruption of autophagy and impaired autophagosome and lysosome function.
Conclusion: Alcohol affects multiple genes in the autophagy pathway and impairs autophagic flux at the lysosome level in ALD. Inhibition of LAMP1 and LAMP2 promotes exosome release in ALD. We identified miR-155 as a mediator of alcohol-related regulation of autophagy and exosome production in hepatocytes and macrophages.
© 2019 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31090940      PMCID: PMC7453183          DOI: 10.1002/hep.30766

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  40 in total

1.  Decreased Macrophage Autophagy Promotes Liver Injury and Inflammation from Alcohol.

Authors:  Ghulam Ilyas; Francesca Cingolani; Enpeng Zhao; Kathryn Tanaka; Mark J Czaja
Journal:  Alcohol Clin Exp Res       Date:  2019-04-29       Impact factor: 3.455

Review 2.  Autophagy and multivesicular bodies: two closely related partners.

Authors:  C M Fader; M I Colombo
Journal:  Cell Death Differ       Date:  2008-11-14       Impact factor: 15.828

3.  Inhibition of spleen tyrosine kinase activation ameliorates inflammation, cell death, and steatosis in alcoholic liver disease.

Authors:  Terence N Bukong; Arvin Iracheta-Vellve; Banishree Saha; Aditya Ambade; Abhishek Satishchandran; Benedek Gyongyosi; Patrick Lowe; Donna Catalano; Karen Kodys; Gyongyi Szabo
Journal:  Hepatology       Date:  2016-07-22       Impact factor: 17.425

4.  Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases.

Authors:  Shashi Bala; Jan Petrasek; Shiv Mundkur; Donna Catalano; Ivan Levin; Jeanine Ward; Hawau Alao; Karen Kodys; Gyongyi Szabo
Journal:  Hepatology       Date:  2012-07-26       Impact factor: 17.425

5.  Up-regulation of microRNA-155 in macrophages contributes to increased tumor necrosis factor {alpha} (TNF{alpha}) production via increased mRNA half-life in alcoholic liver disease.

Authors:  Shashi Bala; Miguel Marcos; Karen Kodys; Timea Csak; Donna Catalano; Pranoti Mandrekar; Gyongyi Szabo
Journal:  J Biol Chem       Date:  2010-11-09       Impact factor: 5.157

Review 6.  mTOR regulation of autophagy.

Authors:  Chang Hwa Jung; Seung-Hyun Ro; Jing Cao; Neil Michael Otto; Do-Hyung Kim
Journal:  FEBS Lett       Date:  2010-01-18       Impact factor: 4.124

7.  Pharmacological promotion of autophagy alleviates steatosis and injury in alcoholic and non-alcoholic fatty liver conditions in mice.

Authors:  Chih-Wen Lin; Hao Zhang; Min Li; Xiwen Xiong; Xi Chen; Xiaoyun Chen; Xiaocheng C Dong; Xiao-Ming Yin
Journal:  J Hepatol       Date:  2013-01-20       Impact factor: 25.083

8.  Following autophagy step by step.

Authors:  Tom Egil Hansen; Terje Johansen
Journal:  BMC Biol       Date:  2011-06-02       Impact factor: 7.431

9.  Biodistribution and function of extracellular miRNA-155 in mice.

Authors:  Shashi Bala; Timea Csak; Fatemeh Momen-Heravi; Dora Lippai; Karen Kodys; Donna Catalano; Abhishek Satishchandran; Victor Ambros; Gyongyi Szabo
Journal:  Sci Rep       Date:  2015-05-29       Impact factor: 4.379

10.  Characterization of mouse serum exosomal small RNA content: The origins and their roles in modulating inflammatory response.

Authors:  Xin Zhou; Zinan Jiao; Juling Ji; Shuyuan Li; Xiaodi Huang; Xiaoshuang Lu; Heng Zhao; Jingwen Peng; Xinya Chen; Qiuhong Ji; Yuhua Ji
Journal:  Oncotarget       Date:  2017-06-27
View more
  43 in total

Review 1.  Biogenesis, physiological functions and potential applications of extracellular vesicles in substance use disorders.

Authors:  Ernest T Chivero; Raghubendra Singh Dagur; Eric S Peeples; Susmita Sil; Ke Liao; Rong Ma; Liang Chen; Channabasavaiah B Gurumurthy; Shilpa Buch; Guoku Hu
Journal:  Cell Mol Life Sci       Date:  2021-04-05       Impact factor: 9.261

2.  Hepatic stellate cell autophagy inhibits extracellular vesicle release to attenuate liver fibrosis.

Authors:  Jinhang Gao; Bo Wei; Thiago M de Assuncao; Zhikui Liu; Xiao Hu; Samar Ibrahim; Shawna A Cooper; Sheng Cao; Vijay H Shah; Enis Kostallari
Journal:  J Hepatol       Date:  2020-05-08       Impact factor: 25.083

Review 3.  Emerging role of extracellular vesicles in liver diseases.

Authors:  Harmeet Malhi
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-09-23       Impact factor: 4.052

Review 4.  Clinical implications of exosome-derived noncoding RNAs in liver.

Authors:  Zhe Wen Zhou; Wei Zheng; Zheng Xiang; Cun Si Ye; Qiao Qiao Yin; Shou Hao Wang; Cheng An Xu; Wen Hao Wu; Tian Chen Hui; Qing Qing Wu; Ling Yun Zhao; Hong Ying Pan; Ke Yang Xu
Journal:  Lab Invest       Date:  2022-01-10       Impact factor: 5.662

Review 5.  Extracellular Vesicles in Non-alcoholic Fatty Liver Disease and Alcoholic Liver Disease.

Authors:  Dongqing Wu; Huaqing Zhu; Hua Wang
Journal:  Front Physiol       Date:  2021-07-14       Impact factor: 4.566

Review 6.  Exosomes as therapeutic vehicles in liver diseases.

Authors:  Jingyi Ding; Ju Wang; Jiajia Chen
Journal:  Ann Transl Med       Date:  2021-04

Review 7.  The Emerging Role of Exosomes in the Treatment of Human Disorders With a Special Focus on Mesenchymal Stem Cells-Derived Exosomes.

Authors:  Soudeh Ghafouri-Fard; Vahid Niazi; Bashdar Mahmud Hussen; Mir Davood Omrani; Mohammad Taheri; Abbas Basiri
Journal:  Front Cell Dev Biol       Date:  2021-07-07

8.  Autophagy activity in cholangiocarcinoma is associated with anatomical localization of the tumor.

Authors:  Gábor Lendvai; Tímea Szekerczés; Ildikó Illyés; Milán Csengeri; Krisztina Schlachter; Erzsébet Szabó; Gábor Lotz; András Kiss; Katalin Borka; Zsuzsa Schaff
Journal:  PLoS One       Date:  2021-06-15       Impact factor: 3.240

9.  Identification of small compounds regulating the secretion of extracellular vesicles via a TIM4-affinity ELISA.

Authors:  Yunfei Ma; Takeshi Yoshida; Kazutaka Matoba; Katsuhiko Kida; Rito Shintani; Yingshi Piao; Jingchun Jin; Taito Nishino; Rikinari Hanayama
Journal:  Sci Rep       Date:  2021-06-29       Impact factor: 4.379

Review 10.  Exosomal microRNAs as diagnostic and therapeutic biomarkers in non-malignant liver diseases.

Authors:  Seonghwan Hwang; Yoon Mee Yang
Journal:  Arch Pharm Res       Date:  2021-06-24       Impact factor: 4.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.